Literature DB >> 21852109

EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas.

Yoshimi Nakata1, Narikazu Uzawa, Ken-Ichiro Takahashi, Jun Sumino, Chieko Michikawa, Hiroaki Sato, Itaru Sonoda, Yoshio Ohyama, Norihiko Okada, Teruo Amagasa.   

Abstract

Although epidermal growth factor receptor (EGFR) is particularly important in the pathogenesis of head and neck squamous cell carcinomas (HNSCCs), conflicting data have been reported on the correlation between EGFR copy number and survival and the association between EGFR copy number and protein expression. Anatomical site of the tumour in HNSCCs may likely contribute to the discordance of the above points as EGFR expression may differ between the sub-sites of HNSCCs. Thus, in this study, we focused on oral tongue squamous cell carcinomas (OTSCCs). To investigate the association between EGFR copy number alteration and overexpression and to determine which is the more reliable prognostic indicator, Fluorescence in situ hybridisation (FISH) and immunohistochemical staining (IHC) were performed at a single institution on samples from 89 patients with OTSCCs undergoing surgery as the primary treatment modality. Thirty-two (36%) of 89 cases demonstrated an EGFR copy number alteration. EGFR protein expression was found in all 89 cases, of which 82.0% showed overexpression. No significant correlation was found between gene copy number and protein overexpression. Gene copy number alteration was significantly associated with reduced disease-free survival (P=0.048) and overall survival (P=0.001). Multivariate Cox proportional hazards analysis demonstrated that EGFR copy number increase was significantly correlated with overall survival (P=0.001). EGFR copy number status is a more reliable indicator than protein overexpression of the survival rate in OTSCCs. FISH analysis of the EGFR status is useful in predicting poor prognosis in OTSCCs.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852109     DOI: 10.1016/j.ejca.2011.07.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.

Authors:  Darawalee Wangsa; Salim Akhter Chowdhury; Michael Ryott; E Michael Gertz; Göran Elmberger; Gert Auer; Elisabeth Åvall Lundqvist; Stefan Küffer; Philipp Ströbel; Alejandro A Schäffer; Russell Schwartz; Eva Munck-Wikland; Thomas Ried; Kerstin Heselmeyer-Haddad
Journal:  Int J Cancer       Date:  2015-08-28       Impact factor: 7.396

2.  Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.

Authors:  Lei Zhen; Desheng Fan; Xianghua Yi; Xinming Cao; Dong Chen; Liming Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis.

Authors:  Shen Keren; Zhang Shoude; Zhao Lu; Yang Beibei
Journal:  Tumour Biol       Date:  2014-03

4.  High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma.

Authors:  Vlad C Sandulache; Chieko Michikawa; Jeffrey N Myers; Curtis R Pickering; Pranav Kataria; Frederico O Gleber-Netto; Diana Bell; Sanchit Trivedi; Xiayu Rao; Jing Wang; Mei Zhao; Samar Jasser
Journal:  Clin Cancer Res       Date:  2018-01-12       Impact factor: 12.531

5.  Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.

Authors:  Kwang-Yu Chang; Shan-Yin Tsai; Shang-Hung Chen; Hsiao-Hui Tsou; Chia-Jui Yen; Ko-Jiunn Liu; Hsun-Lang Fang; Hung-Chang Wu; Bin-Fay Chuang; Shao-Wen Chou; Careen K Tang; Shyun-Yeu Liu; Pei-Jung Lu; Ching-Yu Yen; Jang-Yang Chang
Journal:  J Biomed Sci       Date:  2013-06-27       Impact factor: 8.410

Review 6.  Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma.

Authors:  Paolo Bossi; Carlo Resteghini; Nicholas Paielli; Lisa Licitra; Silvana Pilotti; Federica Perrone
Journal:  Oncotarget       Date:  2016-11-08

7.  MicroRNA‑509 acts as a tumor suppressor in tongue squamous cell carcinoma by targeting epidermal growth factor receptor.

Authors:  Chao Hou; Yan Dong; Fenghe Zhang; Bo Du
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

8.  Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.

Authors:  Claus Wittekindt; Steffen Wagner; Christina Sabine Mayer; Jens Peter Klussmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

9.  EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study.

Authors:  Vanessa Fátima Bernardes; Frederico Omar Gleber-Netto; Sílvia Ferreira de Sousa; Rafael Malagoli Rocha; Maria Cássia Ferreira de Aguiar
Journal:  BMJ Open       Date:  2013-01-28       Impact factor: 2.692

10.  Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.

Authors:  Huayong Zhang; Jianmin Liu; Xiaoyan Fu; Ankui Yang
Journal:  Med Sci Monit       Date:  2017-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.